Cargando…

Median Age at HPV Infection Among Women in the United States: A Model-Based Analysis Informed by Real-world Data

BACKGROUND: The US Advisory Committee for Immunization Practices (ACIP) recommended shared clinical decision-making for human papillomavirus (HPV) vaccination of individuals aged 27 to 45 years (mid-adults) in June 2019. Determining the median age at causal HPV infection and CIN2+ diagnosis based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prabhu, Vimalanand S, Roberts, Craig S, Kothari, Smita, Niccolai, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653628/ https://www.ncbi.nlm.nih.gov/pubmed/34888404 http://dx.doi.org/10.1093/ofid/ofab111

Ejemplares similares

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States
por: Daniels, Vincent, et al.
Publicado: (2021)

HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States
por: Prabhu, Vimalanand S., et al.
Publicado: (2021)

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
por: Daniels, Vincent, et al.
Publicado: (2021)

Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States
por: Rainwater-Lovett, Kaitlin, et al.
Publicado: (2021)

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
por: Kelkar, Sneha S., et al.
Publicado: (2022)

Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer
por: Clifford, Gary M., et al.
Publicado: (2017)

Heterogeneity Between States in the Health and Economic Impact of Measles Immunization in the United States
por: Paternina-Caicedo, Angel, et al.
Publicado: (2018)

Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
por: Zhang, Dongmu, et al.
Publicado: (2018)

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019–2020 Influenza Season in the United States
por: Divino, Victoria, et al.
Publicado: (2021)

Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials
por: Basu, Anirban, et al.
Publicado: (2018)

Influenza Hospitalizations Among American Indian/Alaska Native People and in the United States General Population
por: Gounder, Prabhu P., et al.
Publicado: (2014)

Clinical and Pregnancy Outcomes of Coronavirus Disease 2019 Among Hospitalized Pregnant Women in the United States
por: Ackerman, Christina M, et al.
Publicado: (2021)

A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam
por: Van Anglen, Lucinda J, et al.
Publicado: (2023)

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years
por: Vink, Frederique J, et al.
Publicado: (2022)

Social Determinants of Health and Care Outcomes Among People With HIV in the United States
por: Menza, Timothy W, et al.
Publicado: (2021)

Outpatient Antibiotic Prescribing Practices for Uncomplicated Urinary Tract Infection in Women in the United States, 2002–2011
por: Kobayashi, Miwako, et al.
Publicado: (2016)

1051 Well-child Visits and HPV Vaccination Rates in Privately Insured Females Aged 9-21 Years in the United States, 2007-2012
por: Zhang, Dongmu, et al.
Publicado: (2014)

Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom–Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa( )
por: Aranday-Cortes, Elihu, et al.
Publicado: (2021)

Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021
por: Stoner, Marie C D, et al.
Publicado: (2022)

Assessment of Infectious Diseases Risks From Dental Aerosols in Real-World Settings
por: Choudhary, Shruti, et al.
Publicado: (2022)

Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States
por: Lee, Kyueun, et al.
Publicado: (2021)

Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence
por: Broyles, Michael R
Publicado: (2017)

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Effectiveness of Dalbavancin Compared With Standard of Care for the Treatment of Osteomyelitis: A Real-world Analysis
por: Cain, Alexander R, et al.
Publicado: (2021)

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023)

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

Symptoms of COVID-19 Outpatients in the United States
por: Pullen, Matthew F, et al.
Publicado: (2020)

A Qualitative Study of the Real-world Experiences of Infectious Diseases Fellows Regarding Antibiotic Stewardship
por: Morgan, Jake R, et al.
Publicado: (2018)

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19
por: Webb, Brandon J, et al.
Publicado: (2021)

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
por: Desai, Kamal, et al.
Publicado: (2016)

The safety profile of COVID-19 vaccinations in the United States
por: Singh, Amninder, et al.
Publicado: (2022)

Outpatient Parenteral Therapy for Complicated Staphylococcus aureus Infections: A Snapshot of Processes and Outcomes in the Real World
por: Townsend, Jennifer, et al.
Publicado: (2018)

Real-World Experience With Higher-Than-Recommended Doses of Lamivudine in Patients With Varying Degrees of Renal Impairment
por: Fischetti, Briann, et al.
Publicado: (2018)

Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
por: Hengel, Richard L, et al.
Publicado: (2020)

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021)

Receipt of Baseline Laboratory Testing Recommended by the HIV Medicine Association for People Initiating HIV Care, United States, 2015–2019
por: Weiser, John, et al.
Publicado: (2022)

Immunization Mandates, Vaccination Coverage, and Exemption Rates in the United States
por: Shaw, Jana, et al.
Publicado: (2018)

Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
por: Rayens, Emily, et al.
Publicado: (2022)

Microalbuminuria in Perinatally HIV-Infected Children and Adolescents in the United States
por: Al Hammoud, Roukaya, et al.
Publicado: (2023)

A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program
por: Redell, Mark, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4q6fcfeq5fugegabq893u7o8v1